These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
55 related articles for article (PubMed ID: 7808503)
1. Deferoxamine in thalassemia major. Cazzola M; Locatelli F; De Stefano P N Engl J Med; 1995 Jan; 332(4):271-2; author reply 272-3. PubMed ID: 7808503 [No Abstract] [Full Text] [Related]
2. Deferoxamine treatment during early pregnancy: absence of teratogenicity in two cases. Vaskaridou E; Konstantopoulos K; Kyriakou D; Loukopoulos D Haematologica; 1993; 78(3):183-4. PubMed ID: 8375749 [TBL] [Abstract][Full Text] [Related]
3. Non-transferrin-bound iron during blood transfusion cycles in beta-thalassemia major. Grosse R; Lund U; Caruso V; Fischer R; Janka GE; Magnano C; Engelhardt R; Dürken M; Nielsen P Ann N Y Acad Sci; 2005; 1054():429-32. PubMed ID: 16339692 [TBL] [Abstract][Full Text] [Related]
4. Deferoxamine in thalassemia major. Splendiani G; Tozzo C; Mazzarella V; Casciani CU N Engl J Med; 1995 Jan; 332(4):270-1. PubMed ID: 7808501 [No Abstract] [Full Text] [Related]
5. Deferoxamine in thalassemia major. Lucarelli G; Clift R; Angelucci E N Engl J Med; 1995 Jan; 332(4):271; author reply 272-3. PubMed ID: 7808502 [No Abstract] [Full Text] [Related]
6. Exchange blood transfusions for the treatment of leg ulcerations in thalassemia intermedia. Aessopos A; Kati M; Tsironi M; Polonifi E; Farmakis D Haematologica; 2006 May; 91(5 Suppl):ECR11. PubMed ID: 16709519 [TBL] [Abstract][Full Text] [Related]
8. Desferrioxamine induced urinary iron excretion in thalassemia. Dubey AP; Kumar S; Choudhury P; Talukdar B; Puri RK Indian Pediatr; 1993 Jun; 30(6):775-8. PubMed ID: 8132258 [TBL] [Abstract][Full Text] [Related]
9. Current trends in management of the beta thalassemias. Shah D; Choudhury P; Dubey AP Indian Pediatr; 1999 Dec; 36(12):1229-42. PubMed ID: 10745364 [No Abstract] [Full Text] [Related]
10. Desferrioxamine therapy induces clearance of iron deposits after bone marrow transplantation for thalassemia: case report. Giardini C; La Nasa G; Contu L; Galimberti M; Polchi P; Angelucci E; Baronciani D; Barbanti I; Muretto P; Lucarelli G Bone Marrow Transplant; 1993; 12 Suppl 1():108-10. PubMed ID: 8374548 [No Abstract] [Full Text] [Related]
11. [Measurement of the secretion of growth hormone in patients with thalassemia major]. De Luca G; Maggiolini M; Bria M; Caracciolo M; Lanzino M; Le Pera M; Brancati C; Andò S Minerva Endocrinol; 1993 Sep; 18(3 Suppl 1):62-5. PubMed ID: 7910656 [No Abstract] [Full Text] [Related]
12. Glucose tolerance and beta-cell secretion in patients with thalassaemia major. Mangiagli A; Italia S; Campisi S J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():985-6. PubMed ID: 10091179 [No Abstract] [Full Text] [Related]
13. Sensory neural hearing loss in beta-thalassemia major patients treated with deferoxamine. Shamsian BS; Aminasnafi A; Moghadassian H; Gachkar L; Arzanian MT; Alavi S; Esfehani H; Garallahi F; Amini R Pediatr Hematol Oncol; 2008 Sep; 25(6):502-8. PubMed ID: 18728969 [TBL] [Abstract][Full Text] [Related]
14. [Therapeuetic management of patients with thalassemia major]. Thuret I Bull Soc Pathol Exot; 2001 May; 94(2):95-7. PubMed ID: 11475036 [TBL] [Abstract][Full Text] [Related]
15. Common queries in thalassemia care. Panigrahi I; Marwaha RK Indian Pediatr; 2006 Jun; 43(6):513-8. PubMed ID: 16820660 [TBL] [Abstract][Full Text] [Related]
16. Transfusion-dependent beta thalassemia in Afghanistan: current evidence amid COVID-19 and future recommendations. Qaderi S; Mousavi SH; Ahmadi A; Arif S; Madadi S; Ayoubi S; Lucero-Prisno DE Hematology; 2021 Dec; 26(1):432-434. PubMed ID: 34130618 [No Abstract] [Full Text] [Related]